201 filings
Page 2 of 11
8-K
kx0i94aa9bhw05wk
14 Nov 23
UroGen Pharma Reports Third Quarter 2023 Financial Results
12:00am
EFFECT
fq9pcpeb o6wmpuq835
18 Sep 23
Notice of effectiveness
12:15am
CORRESP
p3hvx0 sp5fqnq
13 Sep 23
Correspondence with SEC
12:00am
UPLOAD
9nurjuid
12 Sep 23
Letter from SEC
12:00am
8-K
051nwfi
11 Sep 23
Departure of Directors or Certain Officers
4:15pm
D
3hw2kej
14 Aug 23
$120.00 mm in equity / options / securities to be acquired, sold $120.00 mm, 8 investors
2:06pm
8-K
ecxos51 tf7ze4hi86uz
10 Aug 23
UroGen Pharma Reports Record JELMYTO Quarterly Sales and Recent Corporate Developments
8:01am
ARS
o9afxaa w0c1a3t
1 Aug 23
Annual report to shareholders
4:27pm
DEFA14A
mbcn2h
1 Aug 23
Additional proxy soliciting materials
4:23pm
8-K
kpxuqaa35o4k1vr
27 Jul 23
UroGen Announces $120 Million Private Placement of Ordinary Shares
9:57am
8-K
znfii9w q3lat8vud6zd
25 Jul 23
Departure of Directors or Certain Officers
4:19pm
8-K
fkz 3sp7cur0srgkagf
11 May 23
UroGen Pharma Meets Revenue Goal, Reports First Quarter 2023 Financial Results and Recent Corporate Developments
8:05am
8-K
994au7
22 Mar 23
UroGen Pharma Reports Highest Revenue Quarter and Significant Full Year 2022 Growth and Recent Corporate Developments
4:06pm